☰

Xianting Ding, Ph.D. - Publications

Affiliations: 
2012 Mechanical Engineering University of California, Los Angeles, Los Angeles, CA 
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 He J, Li H, Mai J, Ke Y, Zhai C, Li JJ, Jiang L, Shen G, Ding X. Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h. Journal of Extracellular Vesicles. 12: e12364. PMID 37654045 DOI: 10.1002/jev2.12364  0.579
2023 Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, ... Ding X, et al. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial. Emerging Microbes & Infections. 2187247. PMID 36872899 DOI: 10.1080/22221751.2023.2187247  0.501
2022 Huang S, Ding X. Precise Design Strategies of Nanotechnologies for Controlled Drug Delivery. Journal of Functional Biomaterials. 13. PMID 36278656 DOI: 10.3390/jfb13040188  0.305
2021 Wang B, Warden AR, Ding X. The optimization of combinatorial drug therapies: strategies and laboratorial platforms. Drug Discovery Today. PMID 34332097 DOI: 10.1016/j.drudis.2021.07.023  0.324
2021 Blasiak A, Lim JJ, Seah SGK, Kee T, Remus A, Chye H, Wong PS, Hooi L, Truong ATL, Le N, Chan CEZ, Desai R, Ding X, Hanson BJ, Chow EK, et al. IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. Bioengineering & Translational Medicine. 6: e10196. PMID 33532594 DOI: 10.1002/btm2.10196  0.313
2020 Chow EK, Wong PK, Ding X. Advances in Technology to Address COVID-19. Slas Technology. 25: 511-512. PMID 33215941 DOI: 10.1177/2472630320969634  0.388
2020 Abdulla A, Wang B, Qian F, Kee T, Blasiak A, Ong YH, Hooi L, Parekh F, Soriano R, Olinger GG, Keppo J, Hardesty CL, Chow EK, Ho D, Ding X. Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention. Advanced Therapeutics. 2000034. PMID 32838027 DOI: 10.1002/adtp.202000034  0.325
2020 Wu S, Fan X, Jiang J, Ho CM, Ding X, Lou Y, Fan G. Validation of a universal and highly sensitive two-dimensional liquid chromatography-tandem mass spectrometry methodology for the quantification of pyrazinamide, ethambutol, protionamide, and clofazimine in different biological matrices. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1151: 122141. PMID 32526663 DOI: 10.1016/J.Jchromb.2020.122141  0.55
2020 Ho D, Quake SR, McCabe ERB, Chng WJ, Chow EK, Ding X, Gelb BD, Ginsburg GS, Hassenstab J, Ho CM, Mobley WC, Nolan GP, Rosen ST, Tan P, Yen Y, et al. Enabling Technologies for Personalized and Precision Medicine. Trends in Biotechnology. PMID 31980301 DOI: 10.1016/J.Tibtech.2019.12.021  0.528
2019 Sun J, Warden AR, Ding X. Recent advances in microfluidics for drug screening. Biomicrofluidics. 13: 061503. PMID 31768197 DOI: 10.1063/1.5121200  0.415
2019 Sun J, Wang B, Warden AR, Cui DX, Ding X. Overcoming multidrug-resistance in bacteria with a two-step process to repurpose and re-combine established drugs. Analytical Chemistry. PMID 31565925 DOI: 10.1021/Acs.Analchem.9B02690  0.419
2019 Ding X, Krutzik PO, Ghaffari AA, Zhaozhi Y, Miranda D, Cheng G, Ho CM, Nolan GP, Sanchez DJ. Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation. Antiviral Research. 104598. PMID 31513822 DOI: 10.1016/J.Antiviral.2019.104598  0.51
2019 Clemens DL, Lee BY, Silva A, Dillon BJ, Masleša-Galić S, Nava S, Ding X, Ho CM, Horwitz MA. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. Plos One. 14: e0215607. PMID 31075149 DOI: 10.1371/Journal.Pone.0215607  0.603
2019 Wu S, Lan L, Jiang J, Ding X, Ho CM, Lou Y, Fan G. Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate. Journal of Pharmaceutical and Biomedical Analysis. 168: 44-54. PMID 30784889 DOI: 10.1016/J.Jpba.2019.02.006  0.489
2017 Rejeeth C, Vivek R, NipunBabu V, Sharma A, Ding X, Qian K. Cancer nanomedicine: from PDGF targeted drug delivery. Medchemcomm. 8: 2055-2059. PMID 30108722 DOI: 10.1039/C7Md00391A  0.386
2017 Zhang T, Sharma A, Li Y, Zhou Y, Ding X. Orthogonal Array composite design to study and optimize antioxidant combinations in the prevention of UVB-induced HSF damage. Journal of Photochemistry and Photobiology. B, Biology. 178: 568-576. PMID 29258053 DOI: 10.1016/J.Jphotobiol.2017.12.007  0.357
2017 Yang J, Liu C, Wang B, Ding X. Feedback System Control Optimized Electrospinning for Fabrication of an Excellent Superhydrophobic Surface. Nanomaterials (Basel, Switzerland). 7. PMID 29027978 DOI: 10.3390/Nano7100319  0.306
2017 Ding X, Njus Z, Kong T, Su W, Ho CM, Pandey S. Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique. Science Advances. 3: eaao1254. PMID 28983514 DOI: 10.1126/Sciadv.Aao1254  0.604
2017 Wong I, Liu W, Ho CM, Ding X. Continuous Adaptive Population Reduction (CAPR) for Differential Evolution Optimization. Slas Technology. 2472630317690318. PMID 28378610 DOI: 10.1177/2472630317690318  0.633
2017 Jia X, Li Y, Sharma A, Li Y, Xie G, Wang G, Jiang J, Cheng Y, Ding X. Application of sequential factorial design and orthogonal array composite design (OACD) to study combination of 5 prostate cancer drugs. Computational Biology and Chemistry. 67: 234-243. PMID 28189106 DOI: 10.1016/J.Compbiolchem.2017.01.010  0.406
2017 Lee BY, Clemens DL, Silva A, Dillon BJ, Masleša-Galić S, Nava S, Ding X, Ho CM, Horwitz MA. Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time. Nature Communications. 8: 14183. PMID 28117835 DOI: 10.1038/Ncomms14183  0.588
2017 Wang B, Ding X, Wang F. Determination of polynomial degree in the regression of drug combinations Ieee/Caa Journal of Automatica Sinica. 4: 41-47. DOI: 10.1109/Jas.2017.7510319  0.311
2017 Sun J, Liu W, Li Y, Gholamipour-Shirazi A, Abdulla A, Ding X. An on-chip cell culturing and combinatorial drug screening system Microfluidics and Nanofluidics. 21. DOI: 10.1007/S10404-017-1959-7  0.428
2016 Lin J, Jiang H, Ding X. Synergistic combinations of five single drugs from Centella asiatica for neuronal differentiation. Neuroreport. PMID 27893605 DOI: 10.1097/Wnr.0000000000000698  0.395
2016 Silva A, Lee BY, Clemens DL, Kee T, Ding X, Ho CM, Horwitz MA. Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model. Proceedings of the National Academy of Sciences of the United States of America. PMID 27035987 DOI: 10.1073/Pnas.1600812113  0.608
2016 Nowak-Sliwinska P, Weiss A, Ding X, Dyson PJ, van den Bergh H, Griffioen AW, Ho CM. Optimization of drug combinations using Feedback System Control. Nature Protocols. 11: 302-15. PMID 26766116 DOI: 10.1038/Nprot.2016.017  0.628
2015 Weiss A, Berndsen RH, Ding X, Ho CM, Dyson PJ, van den Bergh H, Griffioen AW, Nowak-Sliwinska P. A streamlined search technology for identification of synergistic drug combinations. Scientific Reports. 5: 14508. PMID 26416286 DOI: 10.1038/Srep14508  0.59
2015 Liu Q, Zhang C, Ding X, Deng H, Zhang D, Cui W, Xu H, Wang Y, Xu W, Lv L, Zhang H, He Y, Wu Q, Szyf M, Ho CM, et al. Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform. Scientific Reports. 5: 11464. PMID 26088171 DOI: 10.1038/Srep11464  0.606
2015 Weiss A, Ding X, van Beijnum JR, Wong I, Wong TJ, Berndsen RH, Dormond O, Dallinga M, Shen L, Schlingemann RO, Pili R, Ho CM, Dyson PJ, van den Bergh H, Griffioen AW, et al. Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer. Angiogenesis. 18: 233-44. PMID 25824484 DOI: 10.1007/S10456-015-9462-9  0.712
2015 Ding X, Matsuo K, Xu L, Yang J, Zheng L. Optimized combinations of bortezomib, camptothecin, and doxorubicin show increased efficacy and reduced toxicity in treating oral cancer. Anti-Cancer Drugs. 26: 547-54. PMID 25734832 DOI: 10.1097/CAD.0000000000000222  0.351
2014 Ding X, Liu W, Weiss A, Li Y, Wong I, Griffioen AW, van den Bergh H, Xu H, Nowak-Sliwinska P, Ho CM. Discovery of a low order drug-cell response surface for applications in personalized medicine. Physical Biology. 11: 065003. PMID 25427213 DOI: 10.1088/1478-3975/11/6/065003  0.712
2014 Xu H, Jaynes J, Ding X. Combining two-level and three-level orthogonal arrays for factor screening and response surface exploration Statistica Sinica. 24: 269-289. DOI: 10.5705/Ss.2012.210  0.314
2013 Honda Y, Ding X, Mussano F, Wiberg A, Ho CM, Nishimura I. Guiding the osteogenic fate of mouse and human mesenchymal stem cells through feedback system control. Scientific Reports. 3: 3420. PMID 24305548 DOI: 10.1038/Srep03420  0.482
2013 Yu H, Zhang WL, Ding X, Zheng KY, Ho CM, Tsim KW, Lee YK. Optimizing combinations of flavonoids deriving from astragali radix in activating the regulatory element of erythropoietin by a feedback system control scheme. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 541436. PMID 23737836 DOI: 10.1155/2013/541436  0.686
2013 Jaynes J, Ding X, Xu H, Wong WK, Ho CM. Application of fractional factorial designs to study drug combinations. Statistics in Medicine. 32: 307-18. PMID 22859316 DOI: 10.1002/Sim.5526  0.545
2012 Wong I, Ding X, Wu C, Ho CM. Accurate and Effective Live Bacteria Microarray Patterning on Thick Polycationic Polymer Layer Co-Patterned with HMDS. Rsc Advances. 2: 7673-7676. PMID 23418622 DOI: 10.1039/C2Ra20938A  0.592
2012 Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho CM. Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. International Journal of Nanomedicine. 7: 2281-92. PMID 22654513 DOI: 10.2147/Ijn.S27540  0.574
2012 Ye J, Yang J, Zheng J, Ding X, Wong I, Li W, Chen C. Rarefaction and temperature gradient effect on the performance of the Knudsen pump Chinese Journal of Mechanical Engineering. 25: 745-752. DOI: 10.3901/Cjme.2012.04.745  0.486
2012 Ye J, Yang J, Zheng J, Ding X, Wong I, Li W, Chen C. Thermal transpiration effect on the mass transfer and flow behaviors of the pressure-driven hydrogen gas flow International Journal of Hydrogen Energy. 37: 12474-12480. DOI: 10.1016/J.Ijhydene.2012.05.164  0.468
2011 Tsutsui H, Valamehr B, Hindoyan A, Qiao R, Ding X, Guo S, Witte ON, Liu X, Ho CM, Wu H. An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nature Communications. 2: 167. PMID 21266967 DOI: 10.1038/Ncomms1165  0.457
2010 Sanchez DJ, Ding X, Schopf E, Liu Y, Deng JC, Yang S, Cheng Y, Ho CM, Cheng G. Harnessing nanotechnology to create new diagnostics and treatments for infectious disease 2010 10th Ieee Conference On Nanotechnology, Nano 2010. 75-79. DOI: 10.1109/NANO.2010.5697737  0.403
Show low-probability matches.